期刊文献+

利塞膦酸钠片有关物质的方法学研究 被引量:2

Determination method of related substances in risedronate sodium tablets
下载PDF
导出
摘要 目的建立测定利塞膦酸钠片有关物质的高效液相色谱法。方法采用ODS C18色谱柱(5μm,150 mm×4.6mm),以缓冲液(取四丁基溴化铵3.22g加入1 000ml 0.05mol/L氯化铵缓冲液中,用氨水调pH至7.8±0.05)-甲醇-乙腈(2505025)为流动相;柱温:室温;流速:1.0ml/min;检测波长:254nm。结果在高温、酸、碱、氧化、强光降解下用HPLC测定,各杂质峰和主峰均有较好的分离效果,线性关系为Y=1.28×107 X-1.62×105(r=0.999 9),线性良好,稳定性良好。结论该方法测定快速、简单、准确,灵敏度高,适用于利塞膦酸钠片有关物质的测定。 Objective To establish a HPLC method for determination of related substances of risedronate sodium tablets .Methods The C18 column ,5 μm ,150 mm × 4 .6 mm ,the buffer solution (3 .22 g tetrabutyl ammonium bromide was added to a buffer solution of 1 000 ml 0 .05 mol/L ammonium chloride ,then adjusted pH to 7 .8 ±0 .05 by ammonia)methanolacetonitrile =250:50:25 as mobile phase ,column temperature:room temperature ,flow rate:1 .0 ml/min ,detection length:254 nm . Results Determined by HPLC at high temperature ,acid ,alkali degradation ,the main peak and the impurity peaks were separated well ,and the peaks had a linear relationship ,Y=1 .28 × 10^7 X-1 .62 × 10^5 (r=0 .999 9) .Conclusion The method was rapid ,simple ,accurate and sensitive ,and suitable for determination of risedronate sodium tablets related substances .
出处 《药学实践杂志》 CAS 2015年第1期40-43,共4页 Journal of Pharmaceutical Practice
基金 十一五国家科技重大专项"重大新药创制"项目(2009ZX09301003-008-001)
关键词 利塞膦酸钠 有关物质 高效液相色谱法 risedronate sodium related substances HPLC
  • 相关文献

参考文献7

二级参考文献19

  • 1全会标,高勇义.利塞膦酸钠临床研究进展[J].医学综述,2007,13(1):66-68. 被引量:12
  • 2王杰 赵岚峰 等.实用高效液相色谱法的建立[M].科学出版社,1998..
  • 3中华人民共和国药典委员会.中华人民共和国药典,二部[M].北京:化学工业出版社,2000,附录XIX A.191-193.
  • 4中华人民共和国药典委员会,中华人民共和国药典.二部,2000年,191页
  • 5Usui T,J Chromatogr B,1994年,652卷,1期,67页
  • 6Kwong E,J Chromatogr Sci,1990年,28卷,11期,563页
  • 7Carr A J, Thompson PW, Cooper C. Factors assocated with adherence and persistence to hisphosphonate thera- py in osteoporosis.-a cross-section survey[J]. Osteopo- ros Int, 2006,17 :1638-1644.
  • 8Mori HM Anabe M,Kurach I Y,et al. Osteo integration of dental implants in rabbit bone with low mineral den- sity [J]. J Oral Maxillofae Surg, 1997,55 : 351.
  • 9TrabuIus S,Altiparmak MR,Apaydin S,et al. Treatment of renal transplant recipients with low bone mineral density:a randomized prospective trial of alendronate, alfacalcidol,and alendronate combined with alfacalcidol [J]. Transplant Proc, 2008,40 : 160-166.
  • 10Fujimo to T, Niimi A, Sawai T, et al. Effects of steroid induced osteoporosis on osteointegration of titanium im- plants [J ]. Int J Oral Maxillofac Impl, 1998,13 : 183.

共引文献26

同被引文献21

引证文献2

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部